Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
—
—
—
Global Longlife Hospital and Research Limited is a multispecialty hospital operator. The Company's medical services include oncology, ophthalmology, allergy & immunology, pain management, pulmonology, anesthesiology, cardiology, dermatology, critical care, diabetes & endocrinology, GI medicine, gynecology, infectious disease, nephrology and neurology. Its surgical services include CVTS, joint replacement & ortho, general surgery, onco surgery, GI surgery, neurosurgery and ear, nose and throat (ENT). Its radiology services include mammography, CT scan, X-ray, ultrasound, endoscopy, sonography, and others. Its pathology services include microbiology, biochemistry, clinical pathology, cyto pathology, hematology, serology, and others. Its other services include dialysis, pharmacy, ambulance, dietary and physiotherapy.
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
Global Longlife Hospital and Research Ltd - 543520 - Board Meeting Outcome for Financial Results For The Half Year Ended On September 30, 2024 Along With Limited Review Report | Download
Global Longlife Hospital and Research Ltd - 543520 - Board Meeting Outcome for Financial Results For The Half Year Ended On September 30, 2024 Along With Limited Review Report | Download
Global Longlife Hospital and Research Ltd - 543520 - Board Meeting Outcome for Financial Results For The Half Year Ended On September 30, 2024 Along With Limited Review Report | Download
Global Longlife Hospital and Research Ltd - 543520 - Board Meeting Outcome for Financial Results For The Half Year Ended On September 30, 2024 Along With Limited Review Report | Download
Global Longlife Hospital and Research Ltd - 543520 - Financial Results For The Half Year Ended On September 30, 2024 Along With Limited Review Report | Download
Global Longlife Hospital and Research Ltd - 543520 - Financial Results For The Half Year Ended On September 30, 2024 Along With Limited Review Report | Download
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant